Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
about
Mouse hippocampal GABAB1 but not GABAB2 subunit-containing receptor complex levels are paralleling retrieval in the multiple-T-maze.GABA interneurons mediate the rapid antidepressant-like effects of scopolamine.Vanillin and 4-hydroxybenzyl alcohol attenuate cognitive impairment and the reduction of cell proliferation and neuroblast differentiation in the dentate gyrus in a mouse model of scopolamine-induced amnesiaThe potent effects of ginseng root extract and memantine on cognitive dysfunction in male albino rats.Gongjin-Dan Enhances Hippocampal Memory in a Mouse Model of Scopolamine-Induced Amnesia.β-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in RatsActivation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.Main Plant Extracts' Active Properties Effective on Scopolamine-Induced Memory Loss.A Special Extract of Bacopa monnieri (CDRI-08) Restores Learning and Memory by Upregulating Expression of the NMDA Receptor Subunit GluN2B in the Brain of Scopolamine-Induced Amnesic Mice.Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic Models.Reduction in delay discounting due to nicotine and its attenuation by cholinergic antagonists in Lewis and Fischer 344 rats.Dorsal hippocampal brain receptor complexes linked to the protein synthesis-dependent late phase (LTP) in the rat.Comparison of Memory Impairment and Oxidative Stress Following Single or Repeated Doses Administration of Scopolamine in Rat Hippocampus.Cholinergic modulation of spatial learning, memory and navigation
P2860
Q27322584-6461A429-10D3-456E-B130-FB7715FBE345Q27329758-9297267B-072B-4458-B4D9-7D7137A1248DQ33903366-E0D54762-389A-47F6-A68D-54360561D77CQ34648231-02CD5F9E-5F75-4245-96FE-C8519C305F68Q36092576-96704A55-89E1-49D1-AECE-DD1CF1E510D5Q36217822-7C23A3B8-4841-4EE9-8305-DA99509D9EFEQ36807622-432E21FC-7994-453F-81AB-4EBA0BDA3242Q37037197-170F3D97-4754-4B9F-8D19-FF5CC16F9A16Q39153824-4F750B94-BDFA-443B-A132-E2F0F43B88ECQ40493017-F7342AD7-BCB6-4324-A33D-219B06428FE4Q41573979-31B6678B-0826-4F65-9631-863DA2DF3F39Q45069080-8AF2CEF8-A275-4D46-951C-46025FE2F611Q50226134-2864BC1D-8D2B-43D3-99F9-79A27DBDC9A3Q55417106-D7EE58C1-6076-4C6C-9C7B-CEFC5C012CCCQ58765885-9E521D77-98A1-4BD0-BD8B-0FADF33D8403
P2860
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@ast
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@en
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@nl
type
label
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@ast
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@en
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@nl
prefLabel
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@ast
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@en
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@nl
P2093
P2860
P3181
P1433
P1476
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems
@en
P2093
Arnold Pollak
Harald Höger
Soheil Keihan Falsafi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0032082
P407
P50
P577
2012-01-01T00:00:00Z